FDA Approves Vorasidenib: A New Hope for Glioma Patients​
Reading Time: 2 minutes The FDA recently approved vorasidenib for the treatment of Grade 2 astrocytoma or oligodendroglioma the first approval for targeted therapy for such tumors.
FDA Approves Vorasidenib: A New Hope for Glioma Patients​ Read More »
Health News, People Forum